Skip to main content

ReShape Lifesciences to Present at Dawson James 6th Annual Small Cap Growth Conference

Written by Customer Service on . Posted in Public Companies.

SAN CLEMENTE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) — ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, announced Thomas Stankovich, Chief Financial Officer of the Company, will present at the Annual Small Cap Growth Conference hosted by Dawson James Securities on October 21, 2021, at the Wyndham Grand Hotel in Jupiter, Florida.

During Mr. Stankovich’s presentation, he will provide an overview of the Company’s business operations and highlight ongoing value creation efforts across ReShape’s commercial portfolio of weight-loss products and services.

Details of the presentation are below:

Event: 6th Annual Dawson James Small Cap Growth Conference
Date: Thursday, October 21, 2021
Time: 2:25 p.m. ET
Location: Track 1 – Preserve C

Investors participating in the conference who would like to schedule a one-on-one meeting with ReShape’s management may do so by contacting their Dawson James representative or Daniel Kontoh-Boateng of The Ruth Group at dboateng@theruthgroup.com.

An audio webcast of ReShape’s presentation will be available on the investor relations section of the Company’s website, ir.reshapelifesciences.com. Replays of the webcast will be available for 90 days after the date of the presentation.

ABOUT RESHAPE LIFESCIENCES INC. 
ReShape Lifesciences™ is America’s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. reshapecare™ is a virtual weight-management program that supports lifestyle changes for all weight-loss patients led by board certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace™ is an online collection of quality wellness products curated for all consumers to help them achieve their health goals.

CONTACTS
ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contact:
Daniel Kontoh-Boateng
Assistant Vice President
The Ruth Group
646-536-7019
dboateng@theruthgroup.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.